In pancreatic cancer cells treated with 4-AAQB, there is a significant increase in Bax, a significant decrease in Bcl-xL, and a significant increase in the Bax/Bcl-xL ratio, promoting pancreatic cancer cell apoptosis (104). Here, BCL2L1 is linked to familial pancreatic carcinoma.